WO2019132549A1 - Procédé pour la préparation d'alfoscérate de choline, utilisable en tant que matière première alimentaire, à partir de phosphatidylcholine ou de lécithine - Google Patents

Procédé pour la préparation d'alfoscérate de choline, utilisable en tant que matière première alimentaire, à partir de phosphatidylcholine ou de lécithine Download PDF

Info

Publication number
WO2019132549A1
WO2019132549A1 PCT/KR2018/016779 KR2018016779W WO2019132549A1 WO 2019132549 A1 WO2019132549 A1 WO 2019132549A1 KR 2018016779 W KR2018016779 W KR 2018016779W WO 2019132549 A1 WO2019132549 A1 WO 2019132549A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
choline alfoscerate
phosphatidylcholine
reaction
lipase
Prior art date
Application number
PCT/KR2018/016779
Other languages
English (en)
Korean (ko)
Inventor
김병희
김정은
이정은
송예진
이수정
김도희
Original Assignee
숙명여자대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020170182418A external-priority patent/KR101995643B1/ko
Priority claimed from KR1020170182417A external-priority patent/KR101995642B1/ko
Application filed by 숙명여자대학교산학협력단 filed Critical 숙명여자대학교산학협력단
Publication of WO2019132549A1 publication Critical patent/WO2019132549A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Definitions

  • the present invention relates to a process for the preparation of choline alfoscerate which is available as a food source from phosphatidylcholine or lecithin.
  • Choline alfoscerate is a substance called L- ⁇ -glycerylphosphorylcholine ( sn -glycero-3-phosphocholine), which is a phosphatidylcholine (1,2-diacyl- sn -glycero -3-phosphocholine) in which two acyl groups are removed.
  • Choline alfoscerate is an in vivo precursor of the neurotransmitter acetylcholine and phosphatidylcholine, a major component of the cell membrane, and is used as a cognitive enhancer in patients with dementia such as stroke and Alzheimer's disease. Choline alfoscerate was approved by the US FDA as GRAS in November 2012 (GRN No. 419). On the other hand, the use of choline alfoscerate as a food additive or health functional food raw material has not yet been recognized in Korea.
  • Chemical synthesis can be carried out by deacylation of phosphatidylcholine or condensation reaction of glycerol derivative (eg, glycidol, solketal) with phosphocholine donor using an organic solvent as a reaction medium in the presence of a base (eg, Tetrabutylammonium hydroxide (TBAI) .
  • a base eg, Tetrabutylammonium hydroxide (TBAI)
  • phospholipase A 1 phospholipase A 1
  • sn -1 3-site specific lipase
  • phospholipase A 2 phospholipase A 2
  • choline alfoscerate was prepared by hydrolyzing 0.5 g of egg yolk phosphatidylcholine in 100 mL of Tris buffer using sn -1,3 -position specific lipase and phospholipase A 2 as reaction catalysts.
  • Organic solvent extraction and column chromatography are mainly used for the separation and purification of choline alfoscerate synthesized by chemical or enzymatic methods.
  • the organic solvent extraction method is a method of separating and purifying choline alfoscerate by selectively extracting and removing substances having lower polarity than choline alfoscerate using ether, methanol or the like.
  • Column chromatography is a method of sequentially separating and purifying substances in a reaction product such as choline alfoscerate using a polar phase fixed bed (silica, ion exchange resin, etc.) using an organic solvent such as methanol or chloroform as a mobile phase .
  • organic solvents such as ether, methanol and chloroform are not defined as extraction solvents that can be used in the production of functional food ingredients in food circulation or food additive circulation.
  • the standard must be set to control the amount of residual solvent in the production of the product.
  • the present invention relates to a method for producing choline alfoscerate usable as a food raw material from phosphatidylcholine and choline alfoscerate prepared thereby. More specifically, the present invention relates to a method of 1) hydrolyzing phosphatidylcholine under enzyme catalysis using a reaction medium in which water and hexane, which are extraction solvents usable for the production of food raw materials, are used to obtain choline alfoscerate, and 2) The present invention relates to a method for separating and purifying choline alfoscerate with high purity by extracting choline alfoscerate obtained only by the separation process or by extracting choline alfoscerate obtained by using water which is an additional extraction solvent which can be used for producing food raw materials .
  • the present invention also relates to a process for preparing choline alfoscerate which can be used as a food raw material from lecithin and choline alfoscerate prepared thereby. More specifically, the present invention relates to a method for preparing lecithin as a raw material substrate from lecithin, 2) hydrolyzing fractionated lecithin under enzyme catalysis using a reaction medium in which water and hexane, which are extractable solvents, And 3) extracting choline alfoscerate obtained by simply separating the reaction medium from the reaction medium, or adding choline alfoscerate obtained by using water as an extraction solvent which can additionally be used for the production of food ingredients To extract and purify choline alfoscerate.
  • the present invention provides a method for producing a lipase, comprising: 1) adding a mixed solvent of water and hexane and a lipase enzyme to phosphatidylcholine, followed by hydrolysis; 2) removing the lipase enzyme from the reaction product; 3) separating the reactants in step 2); And 4) recovering the water layer from the layered reactant to obtain a water fraction.
  • the present invention also relates to a method for producing lecithin comprising the steps of 1) adding ethanol to lecithin and obtaining an ethanol fraction to prepare fractionated lecithin; 2) adding a mixed solvent of water and hexane and a lipase enzyme to the prepared fractionated lecithin, and hydrolyzing the fraction; 3) removing the lipase enzyme from the reaction product; 4) separating the reaction product of step 3); And 5) recovering the water layer from the layered reactant to obtain a water fraction.
  • the present invention provides choline alfoscerate which can be used as a food raw material produced by the above method.
  • the present invention provides a health functional food for improving cognitive function containing choline alfoscerate as an active ingredient.
  • the present invention relates to a process for the production of choline alfoscerate which can be used as a food raw material from phosphatidylcholine or lecithin.
  • the process for producing choline alfoscerate according to the present invention is characterized by high purity (98 to 99 Weight%) of choline alfoscerate can be effectively produced.
  • the reaction medium is composed of solvents which can be used for food production. After completion of the reaction, it is possible to separate and purify choline alfoscerate with high purity only by simply separating the reaction medium from the reaction medium. Therefore, choline alpase Rate can be effectively produced.
  • the choline alfoscerate prepared by the method of the present invention can be usefully used as a health-aid material such as a cognitive function improving agent for dementia patients.
  • FIG. 1 is a schematic representation of the lipase catalytic hydrolysis of phosphatidylcholine for the production of choline alfoscerate.
  • FIG. 2 is a flow chart generally showing a process for producing choline alfoscerate including an enzyme reaction step of phosphatidylcholine and an isolation purification step.
  • Figure 3 shows the choline alfoscerate content in the reaction product of the hydrolysis of soybean phosphatidylcholine according to the enzyme type (Novozyme 435, Lipozyme® RM IM, Lipozyme® TL IM, immobilized Candida rugosa lipase, Lecitase® Ultra) Fig.
  • FIG. 4 is a graph showing the content of choline alfoscerate in the reaction product of the hydrolysis reaction of soybean phosphatidylcholine as a function of reaction time according to the ratio of water in the reaction medium (20-400% relative to the weight of soybean phosphatidylcholine).
  • Figure 5 shows the results of analysis of the soybean phosphatidylcholine substrate used in the production of choline alfoscerate and the reaction products and the purified products obtained during the production of choline alfoselate using a liquid chromatography-vaporization light scattering detector (LC-ELSD) system This is the chromatogram obtained.
  • PC phosphatidylcholine
  • FFA free fatty acid.
  • FIG. 6 is a flow chart that entirely illustrates the preparation process of choline alfoscerate, including an enzymatic reaction step of lecithin and an isolated purification step.
  • FIG. 7 is a graph showing the content of choline alfoscerate and the content of glycerophosphodiester in a reaction product obtained by hydrolysis of soybean phosphatidylcholine and fractionated soybean lecithin under the Novozym 435 catalyst, which is a reaction-compatible enzyme, as a function of reaction time.
  • Figure 8 shows the chromatograms obtained by analyzing the substrate used for the production of choline alfoscerate and the reaction products and the purified products obtained during the production of choline alfoselate using a liquid chromatography-vaporization light scattering detector (LC-ELSD) system Grams.
  • PC phosphatidylcholine
  • FFA free fatty acid
  • GPL glycerophospholipids
  • GD glycerophosphodiesters.
  • the inventors of the present invention found that when choline alfoscerate is prepared by hydrolyzing soybean phosphatidylcholine using a mixed solvent of water and n- hexane as a reaction medium and phospholipase A 1 as a reaction catalyst, (Bang et al., Food Chem., 190, 201-206, 2016) that the solubility of soybean phosphatidylcholine in the reaction medium was greatly increased (by dissolving phosphatidylcholine to 21 g per 100 mL of the reaction medium).
  • choline alfoscerate was separated and purified by column chromatography using a mixed solvent of methanol and water as a mobile phase by extracting and removing the free fatty acids produced by using ether after the reaction Respectively.
  • the method of producing choline alfoscerate used in this prior study is not suitable for food production because the reaction time is long (eg, 30 hours) and choline alfoscerate is separated and purified using an extraction solvent that is not usable for food production. It is difficult to use it as a food raw material.
  • the present invention relates to a method for producing a polyhydroxyalkanoate comprising the steps of: 1) adding a mixed solvent of water and hexane and a lipase enzyme to phosphatidylcholine, followed by hydrolysis; 2) removing the lipase enzyme from the reaction product; 3) separating the reactants in step 2); And 4) recovering the water layer from the layered reactant to obtain a water fraction.
  • the lipase can be a sn-position nonspecific lipase, more preferably Candida antarctica lipase B, and even more preferably a macroporous anionic but not limited to, Candida antarctic lipase B, which uses a resin as an immobilization carrier.
  • the amount of water in the mixed solvent of water and hexane may be 20 to 400% by weight based on the weight of phosphatidylcholine, but is not limited thereto.
  • the amount of the lipase enzyme may be 5-15 wt% based on the weight of phosphatidylcholine, but is not limited thereto.
  • the hydrolysis reaction is carried out at 50 to 55 ° C for 2 to 12 hours, but is not limited thereto.
  • the amount of water in the mixed solvent of water and hexane is 100 to 200% by weight based on the weight of phosphatidylcholine
  • the amount of the lipase enzyme is 5 to 10% by weight based on the weight of phosphatidylcholine, For 6 hours, but is not limited thereto.
  • the step 3) may further include a step of further separating by adding water and hexane in a volume ratio of 1: 1, but the present invention is not limited thereto.
  • the step of obtaining the water fraction of step 4) may be to remove the free fatty acid present in the hexane layer.
  • choline alfoscerate prepared by the above method can be used as a food raw material.
  • the fractionated lecithin is prepared by adding ethanol to lecithin, stirring the mixture at 60 to 65 ° C for 10 minutes to 1 hour, removing ethanol from the supernatant obtained by centrifuging to obtain an ethanol fraction , but is not limited thereto.
  • the fractionated lecithin may be removed to neutral lipids.
  • the lipase can be a sn-position nonspecific lipase, more preferably Candida antarctica lipase B, and even more preferably a macroporous anionic but not limited to, Candida antarctic lipase B, which uses a resin as an immobilization carrier.
  • the amount of water in the mixed solvent of water and hexane may be 20 to 200% by weight based on the weight of phosphatidylcholine, but is not limited thereto.
  • the amount of the lipase enzyme may be 5-15 wt% based on the weight of phosphatidylcholine, but is not limited thereto.
  • the hydrolysis reaction is carried out at 50 to 55 ° C for 2 to 12 hours, but is not limited thereto.
  • the step 4) may further include a step of further separating by adding water and hexane in a volume ratio of 1: 1, but the present invention is not limited thereto.
  • the step of obtaining the water fraction of step 5) may be to remove the free fatty acid present in the hexane layer.
  • the water fraction in step 5 may contain glycerophosphodiesters containing choline alfoscerate.
  • choline alfoscerate prepared by the above method can be used as a food raw material.
  • phosphatidylcholine (1,2-diacyl- sn -glycero-3-phosphocholine) is a kind of glycerophospholipids, and glycerol, fatty acid, phosphoric acid and choline [CH 2 CH 2 N + 3 ) 3 ], and is a major component of the cell membrane of all animals and plants.
  • the phosphatidylcholine may be purchased and used in the market, or may be directly separated and purified from soybean oil or yolk by a known method in the art.
  • &quot lecithin &quot
  • lecithin &quot is a by-product obtained when purifying egg yolk or soybean oil, and contains glycine phospholipids such as phosphatidylcholine in a large amount and is mainly used as an emulsifier in processed foods such as margarine, chocolate and ice cream, and pharmaceuticals, cosmetics and feed.
  • the fractionated lecithin of the present invention can be prepared either directly or by purchasing fractionated lecithin, which is commercially available.
  • fractionated lecithin containing a large amount of phosphatidylcholine can be prepared by completely removing neutral lipids from lecithin. It is preferable that the content of phosphatidylcholine is as high as possible.
  • soybean lecithin having a phosphatidylcholine content of 10 to 20% by weight or egg yolk lecithin containing 60 to 80% by weight of a higher content of phosphatidylcholine can be used.
  • choline alfoscerate is a substance called L- ⁇ -glycerylphosphorylcholine ( sn -glycero-3-phosphocholine), which is obtained from phosphatidylcholine by two acyl groups group is removed and is represented by the following formula (2).
  • Choline alfoscerate is an in vivo precursor of the neurotransmitter acetylcholine and phosphatidylcholine, a major component of the cell membrane, and is used as a cognitive enhancer in patients with dementia such as stroke and Alzheimer's disease.
  • the phosphatidylcholine is a substrate
  • the mixed solvent of water and hexane is a reaction medium
  • the lipase enzyme acts as a catalyst.
  • Hexane in the reaction medium serves to 1) increase the efficiency and productivity of the phosphatidylcholine, which is a substrate, by increasing the efficiency of the reaction and 2) to dissolve the free fatty acid in the reaction product during the separation of the reaction medium for purification of the reaction product .
  • the water in the reaction medium serves to 1) be used as a substrate for the hydrolysis reaction and 2) to dissolve the choline alfoscerate in the reaction product in the layer separation process of the reaction medium for the purification of the reaction product.
  • the fractionated lecithin is a substrate
  • the mixed solvent of water and hexane is a reaction medium
  • the lipase enzyme acts as a catalyst.
  • hexane increases the solubility of the fractionated lecithin as a substrate to increase the efficiency and productivity of the reaction, and 2) dissolves the free fatty acid in the reaction product in the separation of the reaction medium for purification of the reaction product. do.
  • the water in the reaction medium serves to 1) be used as a substrate for the hydrolysis reaction and 2) to obtain glycerophosphodiesters containing choline alfoscerate in the reaction product by layer separation of the reaction medium for purification of the reaction product .
  • a mixed solvent of water and hexane was used as the reaction medium, and the amount of hexane in the mixed solvent was preferably about 260% (i.e., 4 mL per gram of the substrate) of the fractionated lecithin used as the substrate,
  • the amount may preferably be 20 to 400% by weight relative to the weight of phosphatidylcholine used as the substrate, but the lower the amount of water, the slower the reaction rate, while if the amount of water is too high, the leaching from the solid support promotes , And more preferably 100 to 200% by weight (that is, 1 to 2 mL / g of phosphatidylcholine) relative to the weight of phosphatidylcholine.
  • the reaction medium may be composed of hexane and water in a volume ratio of 4: 1.
  • a mixed solvent of water and hexane was used as the reaction medium, and the amount of hexane in the mixed solvent was preferably about 260% (i.e., 4 mL per gram of the substrate) of the fractionated lecithin used as the substrate, The amount may be 20 to 200% by weight based on the weight of the fractionated lecithin. However, the lower the amount of water, the slower the reaction rate.
  • the reaction medium may be composed of hexane and water in a volume ratio of 4: 1.
  • the steps 3) and 4) are steps of separating the reaction medium which is a mixed solvent of water and hexane to obtain choline alfoscerate produced from phosphatidylcholine And recovering the choline alfoscerate dissolved in the water layer after layer separation.
  • the reaction product obtained from the phosphatidylcholine can be filtered to obtain a reaction product from which the enzyme has been removed.
  • the reaction product is dissolved in a reaction medium composed of water and hexane, which are solvents that can be used in food production.
  • the free fatty acid generated by the hydrolysis of phosphatidylcholine is present in the hexane layer and the choline alfoscerate is dissolved in the water layer.
  • the reaction medium is allowed to stand at room temperature for 30 minutes to separate the water layer, and then dried using a rotary vacuum concentrator or the like to separate and purify only the choline alfoscerate available as a food raw material.
  • the choline alfoscerate content of the purified product (water fraction) obtained after the separation and purification step of the reaction product obtained from the phosphatidylcholine according to the present invention may be 98% by weight or more.
  • the steps 4) and 5) are a step of separating the reaction medium which is a mixed solvent of water and hexane to obtain choline alfoscerate produced from the fractionated lecithin And recovering the choline alfoscerate dissolved in the water layer after layer separation.
  • the reaction product is allowed to stand overnight at 4 to 23 ° C, and then filtered to obtain a reaction product from which the enzyme has been removed. The reason for this is that the final purified product of the reaction product obtained through the settling process exhibits a higher glycerophosphoester content than the final purified product obtained by filtration immediately after the completion of the reaction.
  • the reaction product is dissolved in a reaction medium composed of water and hexane, which are solvents that can be used for food production.
  • a reaction medium composed of water and hexane, which are solvents that can be used for food production.
  • the free fatty acid generated by the hydrolysis of phosphatidylcholine is present in the hexane layer and the glycerophosphodiester Is dissolved in the water layer. Therefore, the reaction medium is left at room temperature for 30 minutes to separate the water layer, and then dried using a rotary vacuum concentrator or the like to separate and purify only the glycerophosphoester containing choline alfoscerate can do.
  • the glycerophosphodiester content of the purified product (water fraction) obtained after the separation and purification step of the reaction product obtained from the fractionated lecithin according to the present invention, including choline alfoscerate, may be 50% by weight or more.
  • the final purified product of the reaction product obtained from the phosphatidylcholine may contain 98-99% by weight of choline alfoscerate.
  • the final purified product of the reaction product obtained from the fractionated lecithin may contain, in addition to choline alfoscerate, L-? -Glycerylphosphorylinositol, L-? -Glycerylphosphoryl And 50-70% by weight of glycerophosphodiesters such as L-alpha-glycerylphosphorylethanolamine.
  • the present invention provides choline alfoscerate which can be used as a food raw material produced by the above method.
  • the purified product of the reaction product obtained from the phosphatidylcholine contains choline alfoscerate in a high purity (98 to 99% by weight), so that it can have a major physiological activity of choline alfoscerate.
  • the purified product of the reaction product obtained from the fractionated lecithin contains 50 to 70% by weight of glycerophosphoester including choline alfoscerate, and thus may have a major physiological activity of choline alfoscerate.
  • Rate may be usefully used in the field of production of foods, medicines and the like containing the above-mentioned effects.
  • the purified product of the reaction product obtained from phosphatidylcholine or lecithin in the present invention is water-soluble as a water fraction, and thus may be usefully used in the production of liquid foods (drinks, tea, etc.) and pharmaceuticals.
  • the present invention provides a health functional food for improving cognitive function containing choline alfoscerate as an active ingredient.
  • the composition can be used as a pharmaceutical composition for improving cognitive function, a food composition, a food additive composition or a health supplement food composition containing the choline alfoscerate as an active ingredient.
  • the form of the health functional food in the present invention is not particularly limited. It can be manufactured in various forms including beverage, granule, tablet, powder, ring, capsule, wire, noodles, confectionery, meat, fish, herb, stew, rice and the like by mixing known ingredient, food additive and the like.
  • the health functional foods of the present invention may contain conventional food additives and, unless otherwise specified, whether or not they are suitable as food additives are subject to the provisions of the General Food and Drug Administration approved by the Food and Drug Administration, Shall be determined according to the relevant standards and standards.
  • the food additives include sugars such as monosaccharides, disaccharides, polysaccharides and sugar alcohols and flavorings such as tau martin, stevia extract, saccharin and aspartame, nutrients, vitamins, edible electrolytes, flavors, coloring agents, , Chocolate, etc.), pectic acid, alginic acid, organic acid, protective colloid thickening agent, pH adjusting agent, stabilizer, preservative, glycerin, alcohol and carbonating agent.
  • sugars such as monosaccharides, disaccharides, polysaccharides and sugar alcohols and flavorings such as tau martin, stevia extract, saccharin and aspartame, nutrients, vitamins, edible electrolytes, flavors, coloring agents, , Chocolate, etc.
  • pectic acid alginic acid, organic acid, protective colloid thickening agent, pH adjusting agent, stabilizer, preservative, glycerin, alcohol and carbonating agent.
  • the health functional food in tablet form may be prepared by granulating a mixture obtained by mixing the active ingredient (choline alfoscerate) of the present invention with an excipient, a binder, a disintegrant, and other additives in a usual manner, Or the mixture can be directly compression-molded.
  • the health functional food of the tablet form may contain a sweetener or the like as needed.
  • the hard capsule of the capsule type health functional food can be prepared by filling the normal hard capsule with the active ingredient of the present invention (choline alfoscerate), and the soft capsule is prepared by mixing the active ingredient with an additive such as an excipient Such as gelatin, into a capsule base.
  • the soft capsule may contain a plasticizer such as glycerin or sorbitol, a coloring agent, a preservative and the like, if necessary.
  • the ring-shaped health functional food can be prepared by molding a mixture of the active ingredient (choline alfoscerate) of the present invention, an excipient, a binder, a disintegrant, and the like by a conventionally known method and, if necessary, It may be applied to the skin, or the surface may be coated with a substance such as starch or talc.
  • the granular health functional food may be prepared by granulating a mixture of the active ingredient (skin care agent) of the present invention with an excipient, a binder, a disintegrant, etc. by a conventionally known method and, if necessary, adding a flavoring agent, ≪ / RTI >
  • the health functional food of the present invention is manufactured and processed in the form of tablets, capsules, powders, granules, liquids, and rings, and is easy to carry, and is easy to take at anytime and anywhere.
  • Soybean phosphatidylcholine (purity> 97%) used in the following experiments was purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA); Soybean lecithin is available from Ilshinwells Co. (Cheongwon, Korea); Novozym 435 [ Candida antarctica lipase B immobilized on a macroporous anionic resin (Lewatit VP OC 1600), Lipozyme RM IM ( Rhizomucor miehei lipase immobilized on an ion-exchange resin, Lipozyme TL IM ( Thermomyces lanuginosus lipase immobilized on silica gel) and Lecitase Ultra (phospholipase A1 from T.
  • Candida antarctica lipase B immobilized on a macroporous anionic resin Lewatit VP OC 1600
  • Lipozyme RM IM Rhizomucor miehei lipas
  • lanuginosus / Fusarium oxysporum were purchased from Novozymes A / S (Bagsvaerd, Denmark); Candida rugosa lipase immobilized on Immobead 150 was purchased from Sigma-Aldrich Chemical Co. (St. Louis, Mo., USA).
  • the fatty acid composition of commercial soybean phosphatidylcholine used as a substrate of the enzyme reaction for producing choline alfoscerate in the present invention is shown in Table 1 below.
  • the main fatty acids of soybean phosphatidylcholine were linoleic acid (62.6 mol%), palmitic acid (15.1 mol%) and oleic acid (11.0 mol%) and the total unsaturated fatty acid content was 81.3 mol%.
  • the choline alfoscerate of the present invention was prepared by hydrolysis using commercially available soybean phosphatidylcholine as a substrate and a mixed solvent of water and hexane as a reaction medium and using lipase as a catalyst.
  • lipozyme RM IM and lipozyme TL IM have sn -1,3 position specificity of neutral fat or phospholipid.
  • Novogym 435 and Candida lucosa lipase are lipases having no specificity in the sn positions of neutral fat or phospholipids.
  • soybean phosphatidylcholine was placed in a batch reactor (15 cm ⁇ 5 cm id), 20 mL of a mixed solvent of water and hexane (16 mL of hexane + 4 mL of water) and 0.4 g of each lipase (10% of substrate weight)
  • the reaction temperature was kept constant by a constant temperature circulating water bath connected to the water jacket of the reactor.
  • the reaction time was set at least 2 hours to 12 hours.
  • the reaction product samples were taken at 0.2, 0.2, and 0.2 hours at reaction times 0, 2, 4, 6, 8, 10, and 12 hours, respectively.
  • a LiChrosorb Si 60 column (250 mm ⁇ 4 mm i.d., 5 ⁇ m particle size, Merck, Darmstadt, Germany) was used as a column and detected using an evaporative light scattering detector (ELSD).
  • the sample injection amount was 20 ⁇ L and the flow rate of the mobile phase was 1 mL / min.
  • the drift tube temperature of ELSD was 60 ° C and nitrogen was supplied at a flow rate of 1.5 L / min.
  • the content of choline alfoscerate in the reaction product measured by the above method was calculated as a function of the reaction time as a percentage of the total content of phosphatidylcholine, lysophosphatidylcholine and choline alfoscerate in the reaction product.
  • the hydrolysis reaction of phosphatidylcholine occurred only when noborg 435 and Lecitase Ultra were used as catalysts. Especially, in the case of noborg 435 catalytic hydrolysis, phosphatidylcholine completely hydrolyzed And converted to choline alfoscerate. On the other hand, in the case of lipozyme RM IM, lipozyme TL IM and Candida lucosa lipase, the hydrolysis reaction of phosphatidylcholine did not occur within the reaction time range.
  • noborg 435 an sn -position specific lyticase, was an enzyme suitable for producing choline alfoscerate.
  • the amount of water in the medium suitable for the Novogym 435 catalytic hydrolysis reaction and the optimal reaction conditions were further investigated in the following experiment, and the suitability of the phosphatidylcholine as a substrate was compared and evaluated.
  • hydrolysis reaction was carried out using noborg 435, which was shown to have the best suitability for reaction with soybean phosphatidylcholine as a substrate.
  • the reaction temperature was maintained at 50 ° C and the amount of water in the medium was maintained while maintaining the amount of enzyme at 10% of the weight of the substrate phosphatidylcholine (20-400% relative to the weight of phosphatidylcholine) in the reaction product.
  • soybean phosphatidylcholine was placed in a batch reactor (15 cm ⁇ 5 cm id), and 16.8 to 32 mL of a mixed solvent of water and hexane (16 mL of hexane + 0.8, 1.6, 2.4, 3.2, ), Novogym 435 0.4 g (10% of substrate weight) was added and stirred at a reaction temperature of 50 ⁇ at a speed of 600 rpm.
  • the reaction temperature was kept constant by a constant temperature circulating water bath connected to the water jacket of the reactor.
  • the reaction time was set at least 1 hour to 6 hours.
  • the reaction product samples were taken at 0, 1, 2, 3, 4, 5 and 6 hours.
  • the content of choline alfoscerate in the reaction product was measured in the same manner as in Example ⁇ 2-1>, and the content of choline alfoscerate in the reaction product according to the amount of water in the medium was measured by using phosphatidylcholine, lysophosphatidylcholine, The percentage of total content of serrate was calculated as a function of reaction time.
  • the choline alfoscerate content of the reaction product obtained at the reaction time of 5 hours when the amount of water was 80% based on the weight of the substrate was 97.2 wt%
  • the choline alfoscerate content of the reaction product obtained at the reaction time of 6 hours was 100.0 wt% .
  • the amount of water was 100%, 200%, 300%, and 400% of the substrate weight
  • the choline alfoscerate contents of the reaction products obtained at the reaction time of 4 hours were 79.3 wt%, 99.7 wt%, 99.7 wt%, 99.9 wt% %
  • the choline alfoscerate content of the reaction product obtained at the reaction time of 5 hours was 100.0% by weight.
  • the phosphatidylcholine completely converted to choline alfoscerate within 5 hours of reaction time when the amount of water was 100% or more of the substrate weight. Based on the above results, the amount of water in the medium suitable for producing choline alfoscerate was selected as 100% or more of the substrate weight.
  • the experiment was designed using a central composite circumscribed (CCC) design with a star point at a distance of 1.414 from the center point of the central composite design.
  • the independent variables for the optimal reaction conditions for the production of choline alfoscerate are the reaction temperature (50-55 ° C), the reaction time (3-5 hours), the amount of water in the medium (100-200% of the weight of phosphatidylcholine) 5 to 15% by weight), and the dependent variable was the choline alfoscerate content (wt%) of the reaction product.
  • the experimental range of each independent variable was coded in five stages of +1.414, +1, 0, -1, -1.414, and 27 items including 16 factorial points, 8 axis points, and 3 center points After setting the conditions, enzyme reaction was performed under each condition.
  • the second-order regression model which predicts the effect of the above four reaction conditions on choline alfoscerate content, is as follows.
  • Y was the dependent variable, ie, choline alfoscerate content
  • X i was the independent variable and was the temperature (Te), the reaction time (RT), the amount of water in the medium (WC) and the enzyme amount (En).
  • the content of choline alfoscerate in the reaction product was measured in the same manner as in Example ⁇ 2-1>, and the content of choline alfoscerate in the reaction product according to the amount of water in the medium was measured by using phosphatidylcholine, lysophosphatidylcholine, Calculated as a percentage of the total content of serrate.
  • the range of the choline alfoscerate content of the reaction product obtained at 27 reaction conditions was 1.0 to 100.0% by weight.
  • the quadratic polynomial regression model showing the relationship between the four reaction factors and the choline alfoscerate content was statistically significant at the 0.01% significance level and evaluated as appropriate at the 5% significance level.
  • the coefficient of determination of the model was calculated as another index to evaluate the fit of the second polynomial regression model.
  • Regression coefficient indicator decision indicating how well the fit to the data used in the derivation of the regression model (R 2) value and the adjusted coefficient of determination (adjusted R 2) value respectively 0.8298 and 0.7787 were regression model the response to the new observation (Q 2 ), which is an indicator of how well we predicted, is 0.6965. Therefore, the explanatory power and the predictive power of the regression model were evaluated to be excellent.
  • the independent variables used in the derivation of the regression model for the novolac 435 catalytic hydrolysis of phosphatidylcholine for the production of choline alfoscerate were selected using the backward elimination method.
  • the reaction temperature (Te), the reaction time (RT), the amount of water in the medium (WC) and the amount of enzyme (En) considered as reaction factors affecting the choline alfoscerate content of the hydrolyzed product of phosphatidylcholine
  • the linear term, the quadratic term that is the square of these factors, and the interaction term between these factors are all inserted into the model as explanatory variables.
  • Regression models for choline alfoscerate content were derived by leaving only significant explanatory variables in the model.
  • the absolute value of the coefficients of the finally selected independent variables in each regression model means the relative influence on the dependent variable, choline alfoscerate content.
  • Second-order regression model for Novogem 435 catalytic hydrolysis of phosphatidylcholine Effect Coefficient p-value Intercept 79.06 ⁇ 0.0001 Linear term Te 12.33 0.0124 RT 28.73 ⁇ 0.0001 WC 15.45 0.0026 En 22.99 ⁇ 0.0001 Quadratic term RT * RT -14.69 0.0396 En * En -14.14 0.0468
  • reaction conditions other than the 27 reaction conditions in Table 2 were additionally set in a given range of the independent variables, and the content of choline alfoscerate in the reaction products obtained under these conditions was regressed Were compared with the choline alfoscerate content predicted using the parental format.
  • the prediction error of the regression model for the choline alfoscerate content ranged from 0.6 to 61.4%.
  • the prediction error of choline alfoscerate content of reaction products obtained at 5 ⁇ 10 conditions with relatively large predicted values was relatively low as 0.6 ⁇ 24.6%.
  • the use of the second regression model derived from the present invention establishes an optimal reaction condition that maximizes the amount of choline alfoscerate produced, so the above regression model is evaluated to be valid.
  • the optimal reaction conditions for the Novogem 435 catalytic hydrolysis of phosphatidylcholine, which maximizes the production of choline alfoscerate were established using the regression model derived from the present invention.
  • the optimum conditions for the reaction temperature, reaction time, amount of water in the medium and amount of enzyme in the reaction products were determined.
  • the optimum conditions were determined by using Optimization function of Design Expert 8.0 program.
  • the content of choline alfoscerate in the reaction product obtained in the above experiment was examined.
  • the amount of water in the reaction medium according to the present invention increases, the stability of the noborg 435 decreases, which makes it difficult to recover the noborg 435 after the reaction. Therefore, in the present invention, the amount of water in the medium is relatively low (Reaction temperature 55 ° C, reaction time 4.9 hours, amount of water 105.9% by weight in the medium, amount of enzyme 9.4% by weight) or similar conditions (reaction temperature 55 ° C, reaction time 6 hours, amount of water in the medium 100% was set as the optimal reaction condition for the Novogem 435 catalytic hydrolysis of phosphatidylcholine to maximize the production of choline alfoscerate.
  • Choline alfoscerate was isolated and purified by subjecting the crude product of soybean phosphatidylcholine produced by Novojim 435 catalytic hydrolysis reaction product prepared under the optimal reaction conditions set forth in the above Example ⁇ 3-1> to reaction and then separating the reaction medium.
  • a water fraction was prepared from the reaction product obtained by hydrolyzing soybean phosphatidylcholine under novolac 435 catalyst, and the choline alfoscerate content of the fraction was measured.
  • soybean phosphatidylcholine was placed in a batch reactor (15 cm ⁇ 5 cm id), 20 mL of a mixed solvent of water and hexane (16 mL of hexane + 4 mL of water) and 0.4 g of Novogym 435 (10% of substrate weight)
  • the reaction was carried out at a reaction temperature of 55 ° C at 600 rpm for 6 hours with stirring.
  • the reaction temperature was kept constant by a constant temperature circulating water bath connected to the water jacket of the reactor.
  • the reaction product was placed in a Buchner funnel with a filter paper, and filtration under reduced pressure was conducted to obtain a reaction product from which novoid 435 enzyme was removed.
  • the remaining reaction product in the reactor was further washed with 20 mL of water into the Buchner funnel and filtered. After filtration, the reaction product was put into a separatory funnel, and further, 20 mL of water and 20 mL of hexane were added, and the mixture was allowed to stand at room temperature for 30 minutes, and the reaction medium was separated into a hexane layer and a water layer.
  • the water layer is recovered and dried at 40 ° C using a rotary vacuum concentrator to purify the choline alpocellate Water (water fraction) was prepared.
  • the content of phosphatidylcholine, lysophosphatidylcholine and choline alfoscerate in the water fraction obtained from the reaction product of soybean phosphatidylcholine was measured in the same manner as in Example ⁇ 2-1>, and the content of each component was measured by phosphatidylcholine, Phosphatidylcholine and choline alfoscerate as a percentage of the total content.
  • the yield of the water fraction obtained from the reaction product of soybean phosphatidylcholine was 31.8% by weight with respect to the weight of soybean phosphatidylcholine choline as a raw material substrate and the choline alfoscerate content of the water fraction was 98.6% by weight.
  • the chemical composition of soybean lecithin used as a raw material in the present invention is shown in detail in Table 8 below.
  • the total lipid content including the glycerophospholipids of the soybean lecithin was ⁇ 90 wt%.
  • the content of phosphatidylcholine (PC) was the highest at ⁇ 15 wt%, and the content of phosphatidylinositol (PI; ⁇ 11 wt%), phosphatidylethanolamine (PE; weight%).
  • the content of lipids other than phospholipids such as neutral lipids was ⁇ 45 wt%.
  • fractionated soybean lecithin ethanol fraction of soy lecithin
  • the fractionated soybean lecithin prepared under the above fractionation conditions was confirmed to have completely removed the neutral lipids.
  • the yield of the obtained fractionated soybean lecithin was ⁇ 48 wt% based on the weight of soybean lecithin.
  • the obtained fractionated soybean lecithin was refrigerated at 4 ° C until use.
  • the major fatty acids of the fractionated soybean lecithin were 51.4 mol% linoleic acid (18: 2n-6), 23.3 mol% oleic acid (18: 1 n-9) and 16.5 mol% palmitic acid : 0) and the total unsaturated fatty acid content was 80.2 mol%.
  • the amount of choline alfoscerate produced in the Novogam 435 catalytic hydrolysis reaction was determined by using the fractionated soybean lecithin and the commercial soybean phosphatidylcholine prepared in Example ⁇ 5-2> as the substrate and the mixed solvent of water and hexane as the reaction medium, Respectively.
  • soybean phosphatidylcholine or fractionated soybean lecithin was placed in a batch reactor (15 cm ⁇ 5 cm id), and 20 mL of a mixed solvent of water and hexane (16 mL of hexane + 4 mL of water) and 0.4 g of Novogym 435 ) was added thereto, followed by stirring at a reaction temperature of 55 ° C at a speed of 600 rpm.
  • the reaction temperature was kept constant by a constant temperature circulating water bath connected to the water jacket of the reactor.
  • the reaction time was set at least 2 hours to 12 hours.
  • the reaction product samples were taken at 0.2, 0.2, and 0.2 hours at reaction times 0, 2, 4, 6, 8, 10, and 12 hours, respectively.
  • a LiChrosorb Si 60 column (250 mm ⁇ 4 mm i.d., 5 ⁇ m particle size, Merck, Darmstadt, Germany) was used as a column and detected using an evaporative light scattering detector (ELSD).
  • the sample injection amount was 20 ⁇ L and the flow rate of the mobile phase was 1 mL / min.
  • the drift tube temperature of ELSD was 60 ° C and nitrogen was supplied at a flow rate of 1.5 L / min.
  • the content of choline alfoscerate in the reaction product measured by the above method was calculated as a function of the reaction time as a percentage of the total content of phosphatidylcholine, lysophosphatidylcholine and choline alfoscerate in the reaction product.
  • GPL glycerophospholipids
  • PI phosphatidylinositol
  • PE phosphatidylethanolamine
  • Lysoglycerophospholipids such as lysophosphatidylinositol (LPI), lysophosphatidyl ethanolamine (LPE), and the like, which are produced from the glycerophospholipid species by the hydrolysis reaction of fractionated soybean lecithin and L- Glycerophosphodiesters (GD) such as L- ⁇ -glycerylphosphorylinositol and L- ⁇ -glycerylphosphorylethanolamine are known as lysophosphatidylcholine and choline alfoscerate
  • the phosphodiester content (including choline alfoscerate content) was measured and the content of each component The content was expressed as a function of the reaction time as a percentage of the total content of glycerophospholipid, lithoglycerol phospholipid and glycerophosphoester in the reaction product.
  • the production amount of glycerophosphoester (20.0 wt%) including choline alfoscerate by the hydrolysis reaction of the fractionated soybean lecithin before the reaction time of 2 hours before the hydrolysis reaction of soybean phosphatidylcholine was higher than that of choline alfoscerate (3.7% by weight).
  • soybean phosphatidylcholine was higher than that of fractionated soybean lecithin after 4 hours of reaction. Especially, soybean phosphatidylcholine is completely converted to choline alfoscerate after 6 hours of reaction, whereas when fractionated soybean lecithin is used as a substrate, glycerophospholipid (including phosphatidylcholine) is completely dissolved in glycerophosphate Ester (including choline alfoscerate).
  • the reaction products obtained from the fractionated soybean lecithin contained three kinds of unknown components (1, 2, and 3 in addition to glycerophosphoester (including choline alfoselate) Peak) were present together. Two of the three unknown components (peaks 1 and 2) were also contained in the fractionated soybean lecithin as a raw material substrate and one (peak 3) was determined to be produced during the reaction.
  • the glycerophosphoester (including choline alfoscerate) was separated from the reaction medium after the reaction by reacting the Novogem 435 catalytic hydrolysis product of the fractionated soybean lecithin prepared under the optimum conditions set up in the previous study Lt; / RTI >
  • a water fraction was prepared from the reaction product obtained by hydrolyzing fractionated soybean lecithin under Novogem 435 catalyst, and the content of glycerophosphoester (including choline alfoscerate) of the fraction was measured.
  • reaction product was placed in a Buchner funnel with a filter paper and filtered under reduced pressure to obtain a reaction product in which novoid 435 enzyme was removed.
  • the remaining reaction product in the reactor was further washed with 20 mL of water into the Buchner funnel and filtered. After filtration, the reaction product was put into a separatory funnel, and further, 20 mL of water and 20 mL of hexane were added, and the mixture was allowed to stand at room temperature for 30 minutes, and the reaction medium was separated into a hexane layer and a water layer.
  • the water layer is recovered and dried using a rotary vacuum concentrator at 40 ° C To give a purified product (water fraction) of glycerophosphoester (including choline alfoscerate).
  • the total glycerol content (including phosphatidylcholine content), the total lithoglycerol phospholipid content (including lysophosphatidylcholine content) and the total glycerophosphoester content (including choline alfoscerate content) in the water fraction obtained from the reaction product of fractionated soybean lecithin ) was measured in the same manner as in Example 7, and the content of each component was expressed as a percentage of the total content of glycerophospholipid, lithoglycerophospholipid and glycerophosphoester in the water fraction.
  • the yield of the water fraction obtained in the reaction product of the fractionated soybean lecithin was 12.0% by weight based on the weight of the fractionated soybean lecithin as the raw material substrate, and the glycerophosphate The ester content was 52.4 wt%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé pour la préparation d'alfoscérate de choline, utilisable en tant que matière première alimentaire, à partir de phosphatidylcholine ou de lécithine, et un procédé de préparation d'alfoscérate de choline selon la présente invention utilise un milieu réactionnel spécifique et une enzyme catalytique spécifique, ce qui permet de préparer efficacement un alfoscérate de choline de pureté élevée. En particulier, le procédé de préparation permet d'utiliser un solvant mélangé constitué d'eau et d'hexane, dans lesquels le substrat a une solubilité élevée et qui est un solvant d'extraction utilisable dans la préparation de matières premières alimentaires, en tant que milieu réactionnel et permet une purification à une pureté élevée de l'alfoscérate de choline uniquement à l'aide d'un procédé de séparation de phases du milieu réactionnel, ce qui permet d'accroître la productivité de l'alfoscérate de choline pour qu'elle soit supérieure à celle d'un procédé de synthèse enzymatique classique, d'avoir, à la différence d'un procédé de synthèse chimique classique et d'un procédé de purification classique, une purification très simple et de permettre la préparation d'alfoscérate de choline qui est utilisable en tant que matière première alimentaire. Plus précisément, la lécithine est une matière première constituée de lécithine fractionnée utilisée en tant que substrat dans le procédé de préparation et est une matière première bon marché obtenue en tant que sous-produit dans un processus de raffinage d'huile de soja et similaire et on s'attend ainsi à ce qu'elle soit très utile dans la commercialisation du procédé de préparation dans le futur. De plus, l'alfoscérate de choline préparé par le procédé selon la présente invention peut être efficacement utilisable en tant que matière pour des aliments, des produits pharmaceutiques et similaires pour l'amélioration de la fonction cognitive chez des patients ayant eu un accident vasculaire cérébral et ayant une démence telle que la maladie d'Alzheimer.
PCT/KR2018/016779 2017-12-28 2018-12-27 Procédé pour la préparation d'alfoscérate de choline, utilisable en tant que matière première alimentaire, à partir de phosphatidylcholine ou de lécithine WO2019132549A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2017-0182418 2017-12-28
KR10-2017-0182417 2017-12-28
KR1020170182418A KR101995643B1 (ko) 2017-12-28 2017-12-28 레시틴으로부터 식품원료로 이용가능한 콜린알포세레이트의 제조방법
KR1020170182417A KR101995642B1 (ko) 2017-12-28 2017-12-28 포스파티딜콜린으로부터 식품원료로 이용가능한 콜린알포세레이트의 제조방법

Publications (1)

Publication Number Publication Date
WO2019132549A1 true WO2019132549A1 (fr) 2019-07-04

Family

ID=67063996

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/016779 WO2019132549A1 (fr) 2017-12-28 2018-12-27 Procédé pour la préparation d'alfoscérate de choline, utilisable en tant que matière première alimentaire, à partir de phosphatidylcholine ou de lécithine

Country Status (1)

Country Link
WO (1) WO2019132549A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227945A1 (en) * 2004-04-09 2005-10-13 Cargill, Incorporated Enzymatic modification of lecithin
KR20060102880A (ko) * 2005-03-25 2006-09-28 주식회사 고센바이오텍 고가공성 레시틴의 제조 방법
US20120244583A1 (en) * 2011-03-24 2012-09-27 Yuanfa Liu Method for Preparing High Purity L-alpha Glycerylphosphorylcholine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227945A1 (en) * 2004-04-09 2005-10-13 Cargill, Incorporated Enzymatic modification of lecithin
KR20060102880A (ko) * 2005-03-25 2006-09-28 주식회사 고센바이오텍 고가공성 레시틴의 제조 방법
US20120244583A1 (en) * 2011-03-24 2012-09-27 Yuanfa Liu Method for Preparing High Purity L-alpha Glycerylphosphorylcholine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAEZA-JIMENEZ, RAMIRO ET AL.: "Enzyme-catalysed Hydrolysis of Phosphatidylcholine for the Production of Lysophosphatidylcholine", J. CHEM. TECHNOL. BIOTECHNOL., vol. 88, no. 10, 2013, pages 1859 - 1863, XP055624189, [retrieved on 20130307] *
BANG, HYO-JEONG ET AL.: "Phospholipase A1-catalyzed Hydrolysis of Soy Phosphatidylcholine to Prepare L-alpha-glycerylphosphorylcholine in Organic-aqueous Media", FOOD CHEMISTRY, vol. 190, 2016, pages 201 - 206, XP055624185, [retrieved on 20150520] *

Similar Documents

Publication Publication Date Title
US5521080A (en) Phospholipase A1, process for its preparation
Comfurius et al. The enzymatic synthesis of phosphatidylserine and purification by CM-cellulose column chromatography
JP4933432B2 (ja) 新規なリン脂質加工剤
JP3853464B2 (ja) 植物性リゾレシチンの製造法
EP1740708B1 (fr) Préparation enzymatíque de produits de lecithine hydrolysée
JP2001504327A (ja) 新規ホスホリパーゼ、その生産及び使用
JP6230601B2 (ja) 脂肪酸の短鎖エステル化におけるリパーゼ
EP1005517A1 (fr) Procede de production de diglycerides
KR20040103979A (ko) 아스타산틴 중쇄 지방산 에스테르, 그 제조법, 및 이들을함유하는 조성물
KR101995643B1 (ko) 레시틴으로부터 식품원료로 이용가능한 콜린알포세레이트의 제조방법
US8530208B2 (en) Method for producing phospholipid
EP1890706B1 (fr) Procede de preparation et d'isolation des phosphatides
WO2019132549A1 (fr) Procédé pour la préparation d'alfoscérate de choline, utilisable en tant que matière première alimentaire, à partir de phosphatidylcholine ou de lécithine
KR101995642B1 (ko) 포스파티딜콜린으로부터 식품원료로 이용가능한 콜린알포세레이트의 제조방법
US5100787A (en) Method for preparing highly purified phosphatidylinositol
AU659126B2 (en) Phospholipid composition, fat and oil composition containing the same and process for producing phosphatidic acids
Kishimura et al. Isolation and characteristics of phospholipase A2 from the pyloric ceca of the starfish Asterina pectinifera
Tani et al. Purification and characterization of proteinaceous inhibitor of lipase from wheat flour
US8637278B2 (en) Method for the enzymatic production of emulsifiers containing mono- and diacylglycerides
WO2023106793A1 (fr) Procédé de production de dérivés de triglycérides de haute pureté contenant une teneur élevée en acide eicosapentanoïque (epa)
Wang et al. Partial hydrolysis of soybean oil by phospholipase A1 to produce diacylglycerol‐enriched oil
KR20110003993A (ko) 포화지방산 저감화 방법 및 포화지방산이 저감된 유지 조성물
JP2006232699A (ja) セレブロシド含有抽出物の製造方法
JPS6248390A (ja) リン脂質の精製法
AU2007205762A1 (en) Process for the production of phospholipids

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18895234

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18895234

Country of ref document: EP

Kind code of ref document: A1